Furthermore, ACE2 is upregulated in the liver and subcutaneous and visceral adipose tissue in obese patients with NAFLD compared to obese controls without NAFLD [21,54,124]. The gene discussed is ACE2; the disease is metabolic dysfunction-associated steatotic liver disease.